ZA855476B - Compounds for site-enhanced delivery of radionuclides and uses thereof - Google Patents

Compounds for site-enhanced delivery of radionuclides and uses thereof

Info

Publication number
ZA855476B
ZA855476B ZA855476A ZA855476A ZA855476B ZA 855476 B ZA855476 B ZA 855476B ZA 855476 A ZA855476 A ZA 855476A ZA 855476 A ZA855476 A ZA 855476A ZA 855476 B ZA855476 B ZA 855476B
Authority
ZA
South Africa
Prior art keywords
radionuclides
site
compounds
enhanced delivery
enhanced
Prior art date
Application number
ZA855476A
Other languages
English (en)
Inventor
Nicholas S Bodor
Original Assignee
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida filed Critical Univ Florida
Publication of ZA855476B publication Critical patent/ZA855476B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • C07D207/402,5-Pyrrolidine-diones
    • C07D207/4042,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
ZA855476A 1984-07-19 1985-07-19 Compounds for site-enhanced delivery of radionuclides and uses thereof ZA855476B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63231484A 1984-07-19 1984-07-19

Publications (1)

Publication Number Publication Date
ZA855476B true ZA855476B (en) 1987-03-25

Family

ID=24535023

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA855476A ZA855476B (en) 1984-07-19 1985-07-19 Compounds for site-enhanced delivery of radionuclides and uses thereof

Country Status (13)

Country Link
EP (1) EP0187832A1 (xx)
JP (1) JPS61106556A (xx)
KR (1) KR900007514B1 (xx)
AU (1) AU4635885A (xx)
CA (1) CA1267899A (xx)
DK (1) DK124786A (xx)
ES (1) ES8704900A1 (xx)
FI (1) FI861118A0 (xx)
GR (1) GR851792B (xx)
NO (1) NO860981L (xx)
PT (1) PT80841B (xx)
WO (1) WO1986000898A1 (xx)
ZA (1) ZA855476B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888427A (en) * 1987-04-07 1989-12-19 University Of Florida Amino acids containing dihydropyridine ring systems for site-specific delivery of peptides to the brain
US5079366A (en) * 1987-04-07 1992-01-07 University Of Florida Quarternary pyridinium salts
EP0301751B1 (en) * 1987-07-31 1993-03-10 Takeda Chemical Industries, Ltd. Pyridinium derivatives, their production and use
DE4107570A1 (de) * 1991-03-07 1992-11-19 Diagnostikforschung Inst Chelate, deren metallkomplexe sowie ihre verwendung in diagnostik und therapie
JP4677863B2 (ja) * 2005-09-05 2011-04-27 堺化学工業株式会社 チオール系光硬化性モノマーおよび光硬化型樹脂組成物
US8701166B2 (en) 2011-12-09 2014-04-15 Blackberry Limited Secure authentication
US10864279B2 (en) 2016-12-16 2020-12-15 Industrial Technology Research Institute Linker-drug and antibody-drug conjugate (ADC) employing the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0224283A3 (en) * 1982-05-18 1988-09-21 University Of Florida Brain-specific drug delivery

Also Published As

Publication number Publication date
ES552072A0 (es) 1987-04-16
PT80841B (en) 1987-06-03
CA1267899A (en) 1990-04-17
EP0187832A1 (en) 1986-07-23
DK124786D0 (da) 1986-03-18
GR851792B (xx) 1985-11-26
NO860981L (no) 1986-05-20
ES8704900A1 (es) 1987-04-16
WO1986000898A1 (en) 1986-02-13
AU4635885A (en) 1986-02-25
KR900007514B1 (ko) 1990-10-11
FI861118A (fi) 1986-03-18
DK124786A (da) 1986-05-20
FI861118A0 (fi) 1986-03-18
JPS61106556A (ja) 1986-05-24
KR860000871A (ko) 1986-02-20
PT80841A (en) 1985-08-01

Similar Documents

Publication Publication Date Title
PH22863A (en) Pyrrolobenzimidazoles and pharmaceutical composition containing them
IL74758A (en) Acyltripeptides and pharmaceutical compositions containing them
DE3565937D1 (en) Medical composition for external application
GB2153678B (en) Pharmaceutical composition
EP0173990A3 (en) External pharmaceutical composition
NZ211145A (en) 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions
GB8414044D0 (en) Administering powdered substances
EP0163178A3 (en) Pharmaceutical composition
NZ212099A (en) Substituted arylhydroxamates and pharmaceutical compositions
GB2155914B (en) Treatment of technetium containing solns
PH21185A (en) 9a-aza-9a-homoerythromycin derivatives and pharmaceutical composition containing them
IL74149A0 (en) Ion chelators and pharmaceutical compositions containing them
GB2153677B (en) Pharmaceutical composition
DE3568578D1 (en) Beta-lactam compound and preparing thereof
ZA855476B (en) Compounds for site-enhanced delivery of radionuclides and uses thereof
GB8523491D0 (en) Medicinal composition
NZ213581A (en) Carboxyalkyldipeptides and pharmaceutical compositions
PH25904A (en) Polycyclic compounds and pharmaceutical formulations containing them
PH21046A (en) Imidazole derivatives and pharmaceutical composition containing said compound
IL74667A (en) Spiro-oxazolidones,-thiazolidones and-imidazolidones and pharmaceutical compositions containing them
PH23343A (en) 8 0( acylaminoergolines and pharmaceutical compositions containing them
GB2161979B (en) Radionuclides
DE3480340D1 (en) Novel radioactive iodospiroperidol and process for its preparation
IL74168A0 (en) 1alpha-hydroxyvitamin d2 analogs and pharmaceutical compositions containing them
JPS57176947A (en) Composition and compound